These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7802722)

  • 21. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.
    Griffin BA; Freeman DJ; Tait GW; Thomson J; Caslake MJ; Packard CJ; Shepherd J
    Atherosclerosis; 1994 Apr; 106(2):241-53. PubMed ID: 8060384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood lipid measurements. Variations and practical utility.
    Cooper GR; Myers GL; Smith SJ; Schlant RC
    JAMA; 1992 Mar; 267(12):1652-60. PubMed ID: 1542176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
    Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
    Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of fibric acid derivatives in the management of risk factors for coronary heart disease.
    Després JP; Lemieux I; Robins SJ
    Drugs; 2004; 64(19):2177-98. PubMed ID: 15456334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.
    Superko HR; Hecht HS
    Am J Cardiol; 2001 Aug; 88(3):260-4. PubMed ID: 11472704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emphasis on high-density lipoprotein cholesterol in patients with coronary artery disease.
    Mailander L; Lavie CJ; Milani RV; Gaudin D
    South Med J; 1993 May; 86(5):508-12. PubMed ID: 8488395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid and lipoprotein profile in physiological pregnancy.
    Lippi G; Albiero A; Montagnana M; Salvagno GL; Scevarolli S; Franchi M; Guidi GC
    Clin Lab; 2007; 53(3-4):173-7. PubMed ID: 17447654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease.
    Schwertner HA; Fischer JR
    Atherosclerosis; 2000 Jun; 150(2):381-7. PubMed ID: 10856530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study.
    Glueck CJ; Laskarzewski PM; Suchindran CM; Chambless LE; Barrett-Connor E; Stewart P; Heiss G; Tyroler HA
    Circulation; 1986 Jan; 73(1 Pt 2):I51-61. PubMed ID: 3940684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multivariate analysis of lipoprotein cholesterol fractions.
    Vogler GP; Rao DC; Laskarzewski PM; Glueck CJ; Russell JM
    Am J Epidemiol; 1987 Apr; 125(4):706-19. PubMed ID: 3826048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid and lipoprotein testing in resource-limited laboratories.
    Myers GL
    Ethn Dis; 2003; 13(2 Suppl 2):S107-9. PubMed ID: 13677424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of plasma lipid levels.
    Brewer HB
    Am J Cardiol; 1989 Oct; 64(13):3G-9G. PubMed ID: 2679028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy.
    Grundy SM
    Am J Cardiol; 1995 Feb; 75(6):45B-52B. PubMed ID: 7863974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current thinking in lipid lowering.
    Ballantyne CM
    Am J Med; 1998 Jun; 104(6A):33S-41S. PubMed ID: 9684850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in plasma lipid and lipoprotein levels in men and women after a program of moderate exercise.
    Brownell KD; Bachorik PS; Ayerle RS
    Circulation; 1982 Mar; 65(3):477-84. PubMed ID: 7055869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.